EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Dynamics of BCR::ABL1 transcript levels and clinical outcomes after switch to second‐line therapy in pediatric chronic myeloid leukemia

Stephanie Sembill iD, Thomas Zerjatke, Micha Winterstein, Tabita Ghete iD, Elke Schirmer, Zofia Wotschofsky, Meinolf Suttorp iD, Manuela Krumbholz, Axel Karow iD, Ingmar Glauche, Markus Metzler

HemaSphere · 2026-03 · 10 (3)

DOI: 10.1002/hem3.70347 ↗

Kurz gefasst

Leserbrief in der Zeitschrift HemaSphere, online erschienen am 24.03.2026. Verfasst von Stephanie Sembill und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Oncology and Hematology, Department of Pediatrics and Adolescent Medicine University Hospital Erlangen, Friedrich-Alexander-Universität Erl…. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Pediatric Oncology and Hematology, Department of Pediatrics and Adolescent Medicine University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) Erlangen Germany.
  • CCC Erlangen-EMN: Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) Erlangen Germany.
  • CCC WERA: Comprehensive Cancer Center Alliance WERA (CCC WERA) Erlangen Germany.
  • BZKF: Bavarian Cancer Research Center (BZKF) Erlangen Germany.
  • Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine TUD Dresden University of Technology Dresden Germany.
  • Pediatric Hemato-Oncology, Carl Gustav Carus Faculty of Medicine TUD Dresden University of Technology Dresden Germany.

ORCID-Profile: Stephanie Sembill, Tabita Ghete, Meinolf Suttorp, Axel Karow

Zitieren

APA

Sembill, S., Zerjatke, T., Winterstein, M., Ghete, T., Schirmer, E., Wotschofsky, Z., Suttorp, M., Krumbholz, M., Karow, A., Glauche, I., & Metzler, M. (2026). Dynamics of BCR::ABL1 transcript levels and clinical outcomes after switch to second‐line therapy in pediatric chronic myeloid leukemia. HemaSphere, 10(3). https://doi.org/10.1002/hem3.70347

Vancouver

Sembill S, Zerjatke T, Winterstein M, Ghete T, Schirmer E, Wotschofsky Z, et al. Dynamics of BCR::ABL1 transcript levels and clinical outcomes after switch to second‐line therapy in pediatric chronic myeloid leukemia. HemaSphere. 2026;10(3). doi:10.1002/hem3.70347

BibTeX
@article{Sembill2026,
  author = {Sembill, Stephanie and Zerjatke, Thomas and Winterstein, Micha and Ghete, Tabita and Schirmer, Elke and Wotschofsky, Zofia and Suttorp, Meinolf and Krumbholz, Manuela and Karow, Axel and Glauche, Ingmar and Metzler, Markus},
  title = {Dynamics of BCR::ABL1 transcript levels and clinical outcomes after switch to second‐line therapy in pediatric chronic myeloid leukemia},
  journal = {HemaSphere},
  year = {2026},
  volume = {10},
  number = {3},
  doi = {10.1002/hem3.70347}
}
Kostenlos starten →